The start of mid-stage testing of PF-07081532 triggers a $10 million milestone payment to Sosei Heptares, which has been working with Pfizer on small-molecule drugs directed at G protein-coupled ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果